Literature DB >> 22237470

Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

S Ramia1, N M Melhem, K Kreidieh.   

Abstract

PURPOSE: Investigation of the injecting drug users (IDUs) population is becoming extremely critical and timely in light of the recent evidence that IDUs now act as the core of hepatitis C virus (HCV) epidemics in developed countries. The purpose of this article, therefore, is not only to review the epidemiology of HCV in the Middle East and North Africa (MENA) region, but also to see whether IDUs were adequately studied and whether harm reduction strategies to be applied for their protection have been set.
METHODS: A literature review was carried out of articles published within the last decade on HCV infection.
RESULTS: The gathered data showed that the population of IDUs is severely under-investigated throughout the whole region, possibly due to religious and cultural impediments.
CONCLUSION: In order to reduce the risk of HCV infection in IDUs, a set of recommendations are advanced emphasizing the urgent need for bio-behavioral studies in this population in order to help identify the source and mode of transmission and the genotypes of HCV involved. These results may allow the development of effective and, yet, socially acceptable intervention strategies. We believe that the role which IDUs play in sustaining HCV infection is also an under-investigated topic in many developing countries. Similar reviews and, hence, interventions should be initiated in these regions.

Entities:  

Mesh:

Year:  2012        PMID: 22237470     DOI: 10.1007/s15010-011-0236-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  150 in total

Review 1.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

2.  Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Seyed Moayed Alavian; Khalil Jafari; Nastaran Yazdi
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht.

Authors:  M M Ansar; A Kooloobandi
Journal:  J Viral Hepat       Date:  2002-09       Impact factor: 3.728

4.  Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon.

Authors:  Ziyad Mahfoud; Kassem Kassak; Khalil Kreidieh; Sarah Shamra; Sami Ramia
Journal:  Virol J       Date:  2010-05-13       Impact factor: 4.099

5.  [High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia].

Authors:  S Ben Othman; N Bouzgarrou; A Achour; T Bourlet; B Pozzetto; A Trabelsi
Journal:  Pathol Biol (Paris)       Date:  2004-07

6.  Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan.

Authors:  Mohammed Al-Jamal; Ameen Al-Qudah; Khaldoon F Al-Shishi; Ameera Al-Sarayreh; Linda Al-Quraan
Journal:  Saudi J Kidney Dis Transpl       Date:  2009-05

7.  Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.

Authors:  R Imani; A Karimi; R Rouzbahani; A Rouzbahani
Journal:  East Mediterr Health J       Date:  2008 Sep-Oct       Impact factor: 1.628

8.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

9.  Hepatitis B virus and hepatitis C virus in pregnant Sudanese women.

Authors:  Rasha M Elsheikh; Ahmed A Daak; Mohamed A Elsheikh; Mubarak S Karsany; Ishag Adam
Journal:  Virol J       Date:  2007-10-24       Impact factor: 4.099

10.  Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

Authors:  Liselotte van Asten; Inge Verhaest; Saida Lamzira; Ildefonso Hernandez-Aguado; Robert Zangerle; Faroudy Boufassa; Giovanni Rezza; Barbara Broers; J Roy Robertson; Raymond P Brettle; Jim McMenamin; Maria Prins; Alexandra Cochrane; Peter Simmonds; Roel A Coutinho; Sylvia Bruisten
Journal:  J Infect Dis       Date:  2004-01-08       Impact factor: 5.226

View more
  6 in total

Review 1.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR.

Authors:  Marzieh Jamalidoust; Mandana Namayandeh; Sadaf Asaei; Nasrin Aliabadi; Mazyar Ziyaeyan
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

3.  The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.

Authors:  Roxana-Delia Trimbitas; Fatima Zahra Serghini; Fatiha Lazaar; Warda Baha; Abderrahim Foullous; Mohammed Essalhi; Abdelouahed El Malki; Abdelkrim Meziane Bellefquih; Abdelouaheb Bennani
Journal:  Virol J       Date:  2014-03-06       Impact factor: 4.099

4.  Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.

Authors:  Víctor Granados-García; Yvonne N Flores; Lizbeth I Díaz-Trejo; Lucia Méndez-Sánchez; Stephanie Liu; Guillermo Salinas-Escudero; Filiberto Toledano-Toledano; Jorge Salmerón
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

Review 5.  Hepatitis C Virus in North Africa: An Emerging Threat.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Mohamed O Ahmed; Aghnyia A Dau; Mohamed M Agnan
Journal:  ScientificWorldJournal       Date:  2016-08-16

6.  Systematic overview of hepatitis C infection in the Middle East and North Africa.

Authors:  Karima Chaabna; Sohaila Cheema; Amit Abraham; Hekmat Alrouh; Albert B Lowenfels; Patrick Maisonneuve; Ravinder Mamtani
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.